Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Candesartan cilexetil/telmisartan/TJ-68

Hypokalaemia: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Yokoyama T, et al. Usefulness of mineralocorticoid receptor antagonists, rather than angiotensin II receptor blockers, for the prevention and treatment of licorice-induced pseudoaldosteronism. Traditional and Kampo Medicine 4: 26-30, No. 1, Apr 2017. Available from: URL: http://doi.org/10.1002/tkm2.1063 -Japan Yokoyama T, et al. Usefulness of mineralocorticoid receptor antagonists, rather than angiotensin II receptor blockers, for the prevention and treatment of licorice-induced pseudoaldosteronism. Traditional and Kampo Medicine 4: 26-30, No. 1, Apr 2017. Available from: URL: http://​doi.​org/​10.​1002/​tkm2.​1063 -Japan
Metadaten
Titel
Candesartan cilexetil/telmisartan/TJ-68
Hypokalaemia: 7 case reports
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31450-9

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Sevelamer

Case report

Apixaban

Case report

Amphotericin-B